Last week, I had the privilege of attending the NYSE Women’s Health Summit, where hundreds of humans and trillions of dollars in investment capital dedicated to advancing women's health came together to explore what's next in and for the sector.
While more details about the event will soon be available in a write-up on our website, I couldn’t wait to share some key insights specifically around the opportunities identified by speakers with you today.
Women's Health Investment Opportunities
Overall it seems we're slowly but surly moving past a definition of women's health limited to reproductive health only. There is an increasing recognition of health conditions predominantly or differently impacting women.
Additionally, speakers emphasized the immense financial opportunities associated with developing best-in-class and first-in-class solutions for women’s health. The quote that particularly struck a chord was, “How big could the endometriosis market actually be, if we had the right solutions?” It made me think about market sizing, and how little data and knowledge we actually have to base assumptions on these days.
Some specific fields that garnered attention from panelists at the event:
1. Autoimmune Diseases: Women are disproportionately affected by autoimmune disease, yet diagnosis and treatment often lag behind.
2. Breast Cancer: There’s a consensus on the need for a paradigm shift in breast cancer diagnostics and early detection methods. Investors are keen to explore advanced technologies and biomarkers beyond traditional mammography.
3. Aging-Related Health Concerns: Beyond menopause, there’s growing interest in addressing the multifaceted health needs of women as they age. Conditions like Alzheimer’s are receiving increased attention.
4. Global Health Initiatives: There was lots of conversation on and off stage about the growing importance of addressing global health disparities in areas such as STIs, pregnancy complications, and contraception. Call to action is to consider the similarities in health challenges faced by women in emerging markets and explore opportunities for impactful solutions on a global scale.
So in conclusion...
Overall it was great to see the women's health conversation move beyond impact into one focused on financial opportunities. Clearly investors are starting to take notice, and to quote Dr. Jill Biden, who delivered the keynote at the event: "The momentum behind women’s health feels unstoppable. Thank you for being a part of this. We can’t let this moment pass us by."
I couldn't agree more.
